Cited 6 times in
SARS-CoV-2 Infection Induces HMGB1 Secretion Through Post-Translational Modification and PANoptosis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 곽만섭 | - |
dc.contributor.author | 남기택 | - |
dc.contributor.author | 박인호 | - |
dc.contributor.author | 신전수 | - |
dc.date.accessioned | 2023-08-09T07:05:25Z | - |
dc.date.available | 2023-08-09T07:05:25Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 1598-2629 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/196048 | - |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces excessive pro-inflammatory cytokine release and cell death, leading to organ damage and mortality. High-mobility group box 1 (HMGB1) is one of the damage-associated molecular patterns that can be secreted by pro-inflammatory stimuli, including viral infections, and its excessive secretion levels are related to a variety of inflammatory diseases. Here, the aim of the study was to show that SARS-CoV-2 infection induced HMGB1 secretion via active and passive release. Active HMGB1 secretion was mediated by post-translational modifications, such as acetylation, phosphorylation, and oxidation in HEK293E/ACE2-C-GFP and Calu-3 cells during SARS-CoV-2 infection. Passive release of HMGB1 has been linked to various types of cell death; however, we demonstrated for the first time that PANoptosis, which integrates other cell death pathways, including pyroptosis, apoptosis, and necroptosis, is related to passive HMGB1 release during SARS-CoV-2 infection. In addition, cytoplasmic translocation and extracellular secretion or release of HMGB1 were confirmed via immunohistochemistry and immunofluorescence in the lung tissues of humans and angiotensin-converting enzyme 2-overexpressing mice infected with SARS-CoV-2. © 2023, Korean Association of Immunologists. All rights reserved. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korea Society for Immunology : Korean Society of Biological Response Modifiers | - |
dc.relation.isPartOf | IMMUNE NETWORK | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | SARS-CoV-2 Infection Induces HMGB1 Secretion Through Post-Translational Modification and PANoptosis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Microbiology (미생물학교실) | - |
dc.contributor.googleauthor | Man Sup Kwak | - |
dc.contributor.googleauthor | Seoyeon Choi | - |
dc.contributor.googleauthor | Jiseon Kim | - |
dc.contributor.googleauthor | Hoojung Lee | - |
dc.contributor.googleauthor | In Ho Park | - |
dc.contributor.googleauthor | Jooyeon Oh | - |
dc.contributor.googleauthor | Duong Ngoc Mai | - |
dc.contributor.googleauthor | Nam-Hyuk Cho | - |
dc.contributor.googleauthor | Ki Taek Nam | - |
dc.contributor.googleauthor | Jeon-Soo Shin | - |
dc.identifier.doi | 10.4110/in.2023.23.e26 | - |
dc.contributor.localId | A00166 | - |
dc.contributor.localId | A01243 | - |
dc.contributor.localId | A01631 | - |
dc.contributor.localId | A02144 | - |
dc.relation.journalcode | J01033 | - |
dc.identifier.eissn | 2092-6685 | - |
dc.identifier.pmid | 37416931 | - |
dc.subject.keyword | HMGB1 protein | - |
dc.subject.keyword | PANoptosis | - |
dc.subject.keyword | Post-translational modification | - |
dc.subject.keyword | Severe acute respiratory syndrome coronavirus 2 | - |
dc.contributor.alternativeName | Kwak, Man Sup | - |
dc.contributor.affiliatedAuthor | 곽만섭 | - |
dc.contributor.affiliatedAuthor | 남기택 | - |
dc.contributor.affiliatedAuthor | 박인호 | - |
dc.contributor.affiliatedAuthor | 신전수 | - |
dc.citation.volume | 23 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | e26 | - |
dc.identifier.bibliographicCitation | IMMUNE NETWORK, Vol.23(3) : e26, 2023-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.